Adherium Receives FDA 510(k) Clearance for Next Generation Smartinhaler

September 6, 2017

The FDA cleared Adherium’s SmartTouch inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler.

The device is installed onto a patient’s inhaler to monitor and encourage medication adherence as part of a self-management plan.

The device records the date and time the inhaler is used and automatically transmits the information to an app on the patient’s phone or tablet.

View today's stories